| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| review article | Q7318358 |
| P2093 | author name string | M Scholz | |
| M Müller | |||
| P Wiedemann | |||
| D Niederwieser | |||
| M Rehak | |||
| J Wiercinska | |||
| P2860 | cites work | Antiphospholipid antibodies in retinal vascular occlusions. A prospective study of 75 patients | Q71992931 |
| Prospective Studies of the Association Between Anticardiolipin Antibody and Outcome of Pregnancy | Q72060395 | ||
| [Anticardiolipin antibodies in vascular occlusions of the eye] | Q72529361 | ||
| The management of thrombosis in the antiphospholipid-antibody syndrome | Q72619159 | ||
| Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: a prospective case-control study | Q73305085 | ||
| Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion | Q77941863 | ||
| Hypercoagulable states in patients with retinal venous occlusion | Q78081224 | ||
| [Therapy of retinal venous vascular occlusions] | Q79863907 | ||
| [Surgical treatments for retinal vein occlusion] | Q79988104 | ||
| Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors | Q81873114 | ||
| Antiphospholipid syndrome: an evolving story | Q28194689 | ||
| Antiphospholipid syndrome in patients with retinal venous occlusion | Q28194893 | ||
| Management of antiphospholipid antibody syndrome: a systematic review | Q28195454 | ||
| Central retinal vein occlusion case-control study | Q28222454 | ||
| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 | ||
| Systemic diseases associated with various types of retinal vein occlusion | Q31857763 | ||
| Antiphospholipid syndrome and retinal vein occlusion in adults. | Q33228815 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop | Q33685960 | ||
| Primary anti-phospholipid antibody syndrome (APS): current concepts | Q34674429 | ||
| Antiphospholipid syndrome: an overview. | Q35099505 | ||
| Duration of anticoagulation following venous thromboembolism: a meta-analysis | Q36224051 | ||
| Looking into the eyes of patients with antiphospholipid syndrome | Q36960948 | ||
| Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age. | Q43843003 | ||
| Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems | Q44059776 | ||
| Central retinal vein occlusion and thrombophilia risk factors | Q44221242 | ||
| Genetic determinants of fasting and post-methionine hyperhomocysteinemia in patients with retinal vein occlusion | Q44523500 | ||
| Anticardiolipin antibodies in patients with retinal vein occlusion and no risk factors: a prospective study | Q44584122 | ||
| Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease | Q44673201 | ||
| Protein Z levels and central retinal vein or artery occlusion | Q46726019 | ||
| Thrombophilic risk factors in patients with central retinal vein occlusion | Q49868813 | ||
| A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. | Q50549660 | ||
| [Antiphospholipid syndrome 2007. Current aspects of laboratory diagnostics and their therapeutic consequences]. | Q52927013 | ||
| The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population | Q61845862 | ||
| Is elevated level of soluble endothelial protein C receptor a new risk factor for retinal vein occlusion? | Q64897843 | ||
| Management of retinal vein occlusion | Q70376785 | ||
| Antiphospholipid-protein antibodies are not an uncommon feature in retinal venous occlusions | Q71606412 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | German | Q188 |
| P921 | main subject | antiphospholipid syndrome | Q582207 |
| P304 | page(s) | 427-434 | |
| P577 | publication date | 2009-05-01 | |
| P1433 | published in | Ophthalmologe | Q15759094 |
| P1476 | title | Antiphospholipid syndrome and retinal vein occlusion. Meta-analysis of Published Studies | |
| P478 | volume | 106 |
| Q34087960 | Relationship between angiotensin I-converting enzyme insertion/deletion gene polymorphism and retinal vein occlusion |
| Q30835869 | Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data |
| Q41739975 | The role of coagulation disorders in patients with retinal vein occlusion |
Search more.